US Broker Ratings

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: High Growth Potential with a 242% Upside

Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology firm, is gaining significant attention from investors due to its promising pipeline in the treatment of inflammatory bowel disease..

Regulus Therapeutics Inc. (RGLS) Stock Analysis: Navigating a Promising Biotech Landscape Amidst Potential Downside

Regulus Therapeutics Inc. (NASDAQ: RGLS), a niche player in the biotechnology sector, has been capturing investor interest with its specialized focus on genetically based orphan diseases...

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Insights Into an 88.21% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biotechnology firm focused on developing groundbreaking treatments for neurodegenerative and endocrine disorders, presents an intriguing investment opportunity with a potential..

Avanos Medical, Inc. (AVNS): Investor Outlook on its Challenging Valuation and Recovery Prospects

Avanos Medical, Inc. (NYSE: AVNS) stands at an intriguing crossroads, positioned within the healthcare sector and specializing in innovative medical device solutions. Despite its pivotal role..

LifeMD, Inc. (LFMD) Stock Analysis: A Healthcare Innovator with Substantial Revenue Growth and Analyst Confidence

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is making waves with its innovative approach to telehealth and impressive financial performance. Based in..

Bicycle Therapeutics (BCYC) Stock Analysis: Evaluating a 253.60% Potential Upside in Biotechnology

In the dynamic world of biotechnology, Bicycle Therapeutics plc (NASDAQ: BCYC) is making waves with its innovative approach to drug development. Headquartered in Cambridge, UK, this..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Aiming for a 62% Upside in Pediatric Orthopedic Innovation

OrthoPediatrics Corp. (NASDAQ: KIDS), a leading innovator in pediatric orthopedic medical devices, continues to attract investor interest with its potential for substantial growth. As of the..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Navigating the Diagnostic Leader’s Growth Amidst Market Dynamics

Fulgent Genetics, Inc. (NASDAQ: FLGT), a significant player in the healthcare sector, operates within the diagnostics and research industry, providing cutting-edge clinical diagnostic and therapeutic development..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unveiling a 113% Potential Upside

In the dynamic realm of biotechnology, Cogent Biosciences, Inc. (NASDAQ: COGT) is garnering significant investor attention with its eye-catching potential upside of 113.72%. As a trailblazer..

Oculis Holding AG (OCS) Stock Analysis: Exploring a 102.84% Potential Upside in Eye-Care Innovation

Investors seeking opportunities in the biotechnology sector might find Oculis Holding AG (OCS) a compelling prospect. As a clinical-stage biopharmaceutical company based in Zug, Switzerland, Oculis..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unpacking a 201% Potential Upside for Patient Investors

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing the attention of investors intrigued by its promising growth prospects in the biotechnology sector. With a market cap of..

InMode Ltd. (INMD) Stock Analysis: A Look at Potential Upside with Strong Return on Equity

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specializes in the medical devices industry, offering innovative minimally invasive aesthetic medical products. With its..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 12% Potential Upside for Investors

InnovAge Holding Corp. (NASDAQ: INNV) operates at the intersection of healthcare and elder care, serving the senior community with a comprehensive suite of medical and ancillary..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring a Potential 232.73% Upside Amidst Strong Analyst Confidence

For investors seeking opportunities in the biotech sector, Arcus Biosciences, Inc. (NASDAQ: RCUS) stands out with its significant potential upside and strong analyst support. Despite recent..

AxoGen, Inc. (AXGN) Stock Analysis: Unveiling a Potential 122% Upside in the Medical Devices Sector

AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the medical devices industry, is making waves with its innovative approach to peripheral nerve regeneration. With a market..

Eton Pharmaceuticals, Inc. (ETON) Growth Potential: Rare Disease Focus with Over 105% Upside

Eton Pharmaceuticals, Inc. (ETON), a burgeoning entity in the healthcare sector, is making waves with its focus on developing and commercializing treatments for rare diseases. With..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Unveiling a Potential 211% Upside in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) presents an intriguing opportunity for investors willing to navigate the high-risk, high-reward landscape of biotechnology stocks. With a current market cap..

HealthStream, Inc. (HSTM) Stock Analysis: Unpacking a 24.10% Potential Upside

HealthStream, Inc. (HSTM), a notable player in the healthcare information services sector, presents an intriguing investment opportunity for those looking to capitalize on technological advancements in..

Keros Therapeutics (KROS) Stock Analysis: Uncovering a 117% Potential Upside in Biotech

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with its innovative approach to treating disorders related to the transforming..

AMN Healthcare Services Inc (AMN) Stock Analysis: Evaluating the 21% Potential Upside Amidst Market Challenges

AMN Healthcare Services Inc (NYSE: AMN) stands as a pivotal player within the healthcare sector, specifically in the medical care facilities industry. Based in Dallas, Texas,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds